396 related articles for article (PubMed ID: 17418971)
1. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric predictors of laryngeal edema.
Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation therapy for head and neck cancer.
Chou WW; Puri DR; Lee NY
Expert Rev Anticancer Ther; 2005 Jun; 5(3):515-21. PubMed ID: 16001958
[TBL] [Abstract][Full Text] [Related]
4. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
5. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.
El-Deiry M; Funk GF; Nalwa S; Karnell LH; Smith RB; Buatti JM; Hoffman HT; Clamon GH; Graham SM; Trask DK; Dornfeld KJ; Yao M
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):879-85. PubMed ID: 16230590
[TBL] [Abstract][Full Text] [Related]
7. Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy.
O'Neill M; Heron DE; Flickinger JC; Smith R; Ferris RL; Gibson M
Am J Clin Oncol; 2011 Oct; 34(5):478-82. PubMed ID: 21537150
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
10. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.
Caglar HB; Tishler RB; Othus M; Burke E; Li Y; Goguen L; Wirth LJ; Haddad RI; Norris CM; Court LE; Aninno DJ; Posner MR; Allen AM
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1110-8. PubMed ID: 18468812
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
12. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
14. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy in the treatment of head and neck cancer.
Eisbruch A
Nat Clin Pract Oncol; 2005 Jan; 2(1):34-9. PubMed ID: 16264854
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
[TBL] [Abstract][Full Text] [Related]
17. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
19. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]